About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Ohio | 979 Studies

Clinical Trials Breast CancerOhio

Breast Cancer Clinical Trials in Ohio

Find 979 clinical trials for breast cancer near Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 979 trials

Active not recruitingCompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyThis trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast…NCT04266249·Birmingham, Alabama and 1007 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsThis study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.NCT07182149·Denver, Colorado and 17 others

TerminatedOral AMXT 1501 Dicaprate in Combination With IV DFMOA Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.NCT05500508·Phoenix, Arizona and 6 others

CompletedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineThe purpose of this phase II, randomized, open-label clinical trial is to study 2 schedules of single-agent Irinotecan in women with metastatic breast cancer who have experienced…NCT00072852·Mobile, Alabama and 65 others

CompletedStudy to Evaluate SID 530 Compared to TaxotereThis is a multi-center, randomized, blinded, two-period, two-sequence, crossover study, with a minimum 3-week washout period between treatments.The study is designed to evaluate…NCT00931008·Miami, Florida and 3 others

RecruitingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationThis is an open-label, multi-center, phase 1b study designed to determine a tolerable dose of CX-5461 administered by IV infusion on Day 1 and Day 8 of a 28-day cycle in patients…NCT04890613·Santa Monica, California and 7 others

TerminatedPhase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast CancerPrimary Objective: To determine whether amcenestrant per overall survival (os) improves progression free survival (PFS) when compared with an endocrine monotherapy of the choice…NCT04059484·Birmingham, Alabama and 108 others

CompletedStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerThis pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer.NCT01764789·Columbus, Ohio

CompletedStudy of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00003906·Huntsville, Alabama and 515 others

CompletedComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsThis pilot clinical trial studies comprehensive gene sequencing in guiding treatment recommendations in patients with metastatic or recurrent solid tumors.NCT01987726·Columbus, Ohio

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

CompletedInterleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsPhase I trial to study the effectiveness of interleukin-12, paclitaxel, and trastuzumab in treating patients who have solid tumors.NCT00028535·Columbus, Ohio

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

TerminatedBintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerThe main purpose of this study was to evaluate bintrafusp alfa monotherapy in participants with triple negative breast cancer (TNBC) who express high levels of HMGA2 as determined…NCT04489940·Newark, Delaware and 44 others

Active not recruitingA Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaciclib work compared to…NCT04975308·Chandler, Arizona and 242 others

CompletedMarimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyRATIONALE: Marimastat may stop the growth of breast cancer by stopping blood flow to the tumor.NCT00003010·Scottsdale, Arizona and 24 others

CompletedSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast tumor cells.NCT00066690·Birmingham, Alabama and 499 others

UnknownPaclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00025688·Springdale, Arkansas and 24 others

UnknownChemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00408408·Little Rock, Arkansas and 441 others

Active not recruitingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsThis is an open-label, Phase 1/2 multicenter dose escalation study in pediatric patients with relapsed or refractory extracranial solid tumors (Phase 1), with additional expansion…NCT02650401·La Jolla, California and 25 others

Page 1 of 49Next

Other Conditions in Ohio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma